Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Epolyrec versus Eprex for renal anemia in hemodialysis patients
IRCT2014120120172N1Phase 4Completed
- Sponsor
- Notarkib Biopharmaceutical
- Start
- Mar 2015
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4 trial of epoetin alfa in anemia of chronic kidney disease (2 arms), sponsored by Notarkib Biopharmaceutical. Started Mar 2015; status: completed.
02
Drugs
epoetin alfa
03
Conditions
anemia of chronic kidney disease
Beyond the preview
Go deeper on IRCT2014120120172N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2014120120172N1.